comparemela.com
  1. Home
  2. Live Updates
  3. Synaffix Glycoconnect - Breaking News

Latest Breaking News On - Synaffix glycoconnect - Page 1 : comparemela.com

Mersana, Janssen partner to discover new ADC product candidates

Mersana and Janssen Biotech have signed research collaboration and license agreement to discover antibody-drug conjugates (ADCs) for three targets.

Anna protopapasSynaffix glycoconnect

Synaffix Announces Expansion of Mersana License Deal to a Total Potential Value Exceeding $1 Billion

/PRNewswire/ Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug.

Noord hollandInnovent biologicsAnna protopapasSynaffix glycoconnectPlatform technologyMersana therapeutics incMersana therapeuticsChief executive officerKyowa kirinShanghai miracogenBiogeneration venturesBoth glycoconnect

Synaffix Announces Expansion of Mersana License Deal to a Total Potential Value Exceeding $1 Billion

/PRNewswire/ Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug.

Noord hollandInnovent biologicsAnna protopapasSynaffix glycoconnectPlatform technologyMersana therapeutics incMersana therapeuticsChief executive officerKyowa kirinShanghai miracogenBiogeneration venturesBoth glycoconnect

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.